Regulatory T-cell therapy for Crohn's disease: In vivo veritas

Gastroenterology

Volumn 143, Issue 5, 2012, Pages 1135-1138

  Danese, Silvio ^a,b   Fiorino, Gionata ^a,b   Rutella, Sergio ^a,b  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84868028136     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.09.019     Document Type: Editorial

References (20)

1. S. Danese, J.F. Colombel, W. Reinisch Infliximab for Crohn's disease treatment-shifting therapeutic strategies after 10 years of clinical experience Aliment Pharmacol Ther 33 2011 857 869
2. S. Danese New therapies for inflammatory bowel disease: from the bench to the bedside Gut 61 2012 918 932
3. S. Sakaguchi, N. Sakaguchi, M. Asano Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25) Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases J Immunol 155 1995 1151 1164
4. M.G. Roncarolo, S. Gregori, M. Battaglia Interleukin-10-secreting type 1 regulatory T cells in rodents and humans Immunol Rev 212 2006 28 50
5. + regulatory T cells in the human immune system Nat Rev Immunol 10 2010 490 500
6. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis Nature 389 1997 737 742
7. + regulatory T cells J Immunol 170 2003 3939 3943
8. + T cells during cure of colitis J Immunol 177 2006 5852 5860
9. high T cells in inflammatory bowel disease Gastroenterology 128 2005 1868 1878
10. D.H. Reikvam, G. Perminow, L.G. Lyckander Increase of regulatory T cells in ileal mucosa of untreated pediatric Crohn's disease patients Scand J Gastroenterol 46 2011 550 560
11. M.C. Fantini, A. Rizzo, D. Fina Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression Gastroenterology 136 2009 1308 1316
12. M. Di Ianni, F. Falzetti, A. Carotti Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation Blood 117 2011 3921 3928
13. C.G. Brunstein, J.S. Miller, Q. Cao Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics Blood 117 2011 1061 1070
14. K.L. Hippen, S.C. Merkel, D.K. Schirm Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity Sci Transl Med 3 2011 83ra41
15. A. Di Stasi, S.K. Tey, G. Dotti Inducible apoptosis as a safety switch for adoptive cell therapy N Engl J Med 365 2011 1673 1683
16. E. Elinav, N. Adam, T. Waks Amelioration of colitis by genetically engineered murine regulatory T cells redirected by antigen-specific chimeric receptor Gastroenterology 136 2009 1721 1731
17. P. Desreumaux, A. Foussat, M. Allez Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease Gastroenterology 143 2012 1207 1217
18. P.J. Mannon, F. Leon, I.J. Fuss Successful granulocyte-colony stimulating factor treatment of Crohn's disease is associated with the appearance of circulating interleukin-10-producing T cells and increased lamina propria plasmacytoid dendritic cells Clin Exp Immunol 155 2009 447 456
19. I. Ricciardelli, K.J. Lindley, M. Londei Anti tumour necrosis-α therapy increases the number of FOXP3 regulatory T cells in children affected by Crohn's disease Immunology 125 2008 178 183
20. J. Koreth, K. Matsuoka, H.T. Kim Interleukin-2 and regulatory T cells in graft-versus-host disease N Engl J Med 365 2011 2055 2066